Nutriband Inc. Warrant

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse-deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate, and has a commercial development and clinical supply agreement for AVERSA Fentanyl with Kindeva Drug Delivery. Nutriband was incorporated in 2016 and is headquartered in Orlando, Florida.